284 related articles for article (PubMed ID: 23051697)
41. Initial results of the National Colorectal Cancer Screening Program in Lithuania.
Poskus T; Strupas K; Mikalauskas S; Bitinaitė D; Kavaliauskas A; Samalavicius NE; Saladzinskas Z
Eur J Cancer Prev; 2015 Mar; 24(2):76-80. PubMed ID: 25370682
[TBL] [Abstract][Full Text] [Related]
42. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
[TBL] [Abstract][Full Text] [Related]
43. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.
Park CH; Kim NH; Park JH; Park DI; Sohn CI; Jung YS
Gastrointest Endosc; 2018 Jul; 88(1):128-135. PubMed ID: 29510145
[TBL] [Abstract][Full Text] [Related]
44. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test.
Crotta S; Segnan N; Paganin S; Dagnes B; Rosset R; Senore C
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):633-8. PubMed ID: 22426085
[TBL] [Abstract][Full Text] [Related]
45. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
46. Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use.
Rozen P; Comaneshter D; Levi Z; Hazazi R; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Cancer; 2010 May; 116(9):2115-25. PubMed ID: 20186820
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of nonpolypoid colorectal neoplasms in symptomatic patients scheduled for colonoscopy: a study with total colonic chromoscopy.
Bustamante-Balén M; Bernet L; Cano R; Pertejo V; Ponce J
J Clin Gastroenterol; 2010 Apr; 44(4):280-5. PubMed ID: 19713863
[TBL] [Abstract][Full Text] [Related]
49. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R
Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196
[No Abstract] [Full Text] [Related]
50. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.
Quintero E; Castells A; Bujanda L; Cubiella J; Salas D; Lanas Á; Andreu M; Carballo F; Morillas JD; Hernández C; Jover R; Montalvo I; Arenas J; Laredo E; Hernández V; Iglesias F; Cid E; Zubizarreta R; Sala T; Ponce M; Andrés M; Teruel G; Peris A; Roncales MP; Polo-Tomás M; Bessa X; Ferrer-Armengou O; Grau J; Serradesanferm A; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; de la Vega-Prieto M; Reyes-Melian JM; Cacho G; Díaz-Tasende J; Herreros-de-Tejada A; Poves C; Santander C; González-Navarro A;
N Engl J Med; 2012 Feb; 366(8):697-706. PubMed ID: 22356323
[TBL] [Abstract][Full Text] [Related]
51. Should prior FIT results be incorporated as an additional variable to estimate risk of colorectal neoplasia? A prospective study of 5,813 screening colonoscopies.
Wong MC; Ching JY; Chan VC; Shum JP; Lam TY; Luk AK; Sung JJ
PLoS One; 2014; 9(12):e114332. PubMed ID: 25479102
[TBL] [Abstract][Full Text] [Related]
52. [Colonoscopic screening in first-degree relatives of patients with sporadic colorectal cancer].
Scintu F; Canalis C; Capra F; D'Alia G; Giordano M; Mocci P; Pisano M; Casula G
Ann Ital Chir; 2000; 71(6):693-9. PubMed ID: 11347322
[TBL] [Abstract][Full Text] [Related]
53. Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
Yonsei Med J; 2017 Jan; 58(1):150-157. PubMed ID: 27873508
[TBL] [Abstract][Full Text] [Related]
54. Effectiveness of repeated screening using the fecal occult blood test and its impact on reducing false-negative cancer cases.
Nishida H; Urano S
Eur J Cancer Prev; 2011 May; 20(3):184-9. PubMed ID: 21301345
[TBL] [Abstract][Full Text] [Related]
55. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
56. Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions.
Wong MC; Ching JY; Chiu HM; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Ng SC; Wu JC; Chan FK; Sung JJ
Am J Gastroenterol; 2016 Nov; 111(11):1621-1629. PubMed ID: 26977757
[TBL] [Abstract][Full Text] [Related]
57. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
[TBL] [Abstract][Full Text] [Related]
58. The factors associated with negative colonoscopy in screening subjects with positive immunochemical stool occult blood test outcomes.
Ting PH; Lin XH; Jiang JK; Luo JC; Chen PH; Wang YP; Hsin IF; Perng CL; Hou MC; Lee FY
J Chin Med Assoc; 2018 Sep; 81(9):759-765. PubMed ID: 29778550
[TBL] [Abstract][Full Text] [Related]
59. Patients with sporadic duodenal adenoma are a high-risk group for advanced colorectal neoplasia: results of a case-control study.
Pequin P; Manfredi S; Quentin V; Heresbach D; Boyer J; Siproudhis L; Bretagne JF
Aliment Pharmacol Ther; 2007 Jul; 26(2):277-82. PubMed ID: 17593073
[TBL] [Abstract][Full Text] [Related]
60. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history.
Rex DK; Lehman GA; Ulbright TM; Smith JJ; Pound DC; Hawes RH; Helper DJ; Wiersema MJ; Langefeld CD; Li W
Am J Gastroenterol; 1993 Jun; 88(6):825-31. PubMed ID: 8503374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]